Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 year ago

Vascular Disease and Surgery
Immune Cell Traits and Aortic Dissection: A Mendelian Randomisation Study
Author(s): Tian-le Li , Mao-long Fu , Li-hong Wang , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Inherited and Congenital Cardiac Conditions
Lifetime Management of Aortic Stenosis with Dr Samineh Sehatbakhsh
Author(s): Samineh Sehatbakhsh Added: 7 months ago
Explore comprehensive lifetime management strategies for aortic stenosis with Dr Samineh Sehatbakhsh, addressing the evolving landscape of treatment options for patients across all risk categories.This detailed presentation, part of the Complex Cases track, examines the critical decision-making process between TAVR and surgical aortic valve replacement in the modern era. Dr Sehatbakhsh addresses… View more

Intervention
Complex Cases: Aortic Stenosis in Women with Prof Karam
Author(s): Nicole Karam Added: 8 months ago
Discover the sex-specific challenges in aortic stenosis diagnosis and management with Prof Nicole Karam (European Hospital Georges Pompidou, Paris, FR).This presentation, part of a comprehensive two-part series on complex cases in interventional cardiology, explores the critical pathophysiological differences between men and women that impact diagnostic approaches and therapeutic decision-making… View more

Demographic

Intervention
LV Health Does Not Alter Early TAVR Benefit in Aortic Stenosis
Added: 1 month ago Source:  Radcliffe Cardiology
An exploratory analysis of the EARLY TAVR trial has found that the benefits of early transcatheter aortic valve replacement (TAVR) for asymptomatic severe aortic stenosis (AS) are consistent, regardless of baseline left ventricular (LV) health.¹ This suggests that waiting for LV deterioration may not be the optimal strategy for timing intervention.MethodologyThis analysis used data from the EARLY… View more

Imaging & Diagnostics

Intervention
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Intervention
Job title: Director
Dr AntonioP Gasparis is a Professor of Surgery, Director - Center for Vein Care, Medical Director at Non-Invasive Vascular Laboratory, Medical Director at Bellavie MedSpa, Director at Phlebology Fellowship - Stony Brook University Medical Center, Stony Brook, NY, US. Dr Gasparis obtained his medical degree from SUNY-Syracuse in 1996 and his residency in general surgery. Clinical Interests… View more
Job title: Professor of Surgery
Dr Antonios P Gasparis ia a Professor of Surgery, Director - Center for Vein Care, Medical Director at Non-Invasive Vascular Laboratory, Medical Director at Bellavie MedSpa, Director at Phlebology Fellowship - Stony Brook University Medical Center, Stony Brook, NY, US. Dr Gasparis obtained his medical degree from SUNY-Syracuse in 1996 and his residency in general surgery. Dr Antonios… View more
Cha Rajakaruna
Job title: Consultant Cardiac Surgeon, Bristol Heart Institute, Bristol, UK
Mr. Cha Rajakaruna is a highly esteemed consultant cardiothoracic surgeon specializing in minimally invasive aortic valve replacement, coronary bypass surgery, atrial fibrillation, atrial fibrillation ablation, TAVI (transcatheter aortic valve implantation), and minimally invasive aortic valve repair. He currently practices at Spire Bristol Hospital.Mr. Rajakaruna earned his medical degree (MB… View more
EuroPCR 25: LANDMARK 1Y Outcomes
Author(s): Patrick W Serruys Added: 10 months ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary… View more

Intervention

Vascular Disease and Surgery